Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
4 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
5 Acute myeloid leukemia 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Acute myeloid leukemia 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
7 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
8 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
9 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
10 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
11 Acute myeloid leukemia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
12 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
13 Adherens junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
14 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
15 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
16 Adherens junction 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
17 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
18 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
19 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
20 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
21 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
22 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
23 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
24 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
25 African trypanosomiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
26 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
27 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
28 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
29 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
30 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
31 Alcoholic liver disease 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Alcoholic liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
33 Alcoholism 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
34 Alcoholism 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
35 Alcoholism 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
36 Alcoholism 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
37 Alcoholism 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
38 Alcoholism 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
39 Alcoholism 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
40 Allograft rejection 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
41 Allograft rejection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
42 Alzheimer disease 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
43 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
44 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
45 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
46 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
47 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
48 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
49 Alzheimer disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
50 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
51 Alzheimer disease 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
52 Alzheimer disease 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
53 Alzheimer disease 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
54 Alzheimer disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
55 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
56 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
57 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
58 Amoebiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
59 Amphetamine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
60 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
61 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
62 AMPK signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
63 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
64 Amyotrophic lateral sclerosis 💬
 1件: ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
65 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
66 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
67 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
68 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
69 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
70 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
71 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
72 Antifolate resistance 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
73 Antifolate resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
74 Antigen processing and presentation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
75 Antigen processing and presentation 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
77 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
78 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
79 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
80 Apelin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
81 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
82 Apelin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
83 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
84 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
85 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
86 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
87 Apoptosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
88 Apoptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
89 Apoptosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
90 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
91 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
92 Arachidonic acid metabolism 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
93 Asthma 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
94 Asthma 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
95 Autoimmune thyroid disease 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
96 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
97 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
98 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
99 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
100 Autophagy - animal 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
101 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
102 Autophagy - animal 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
103 Autophagy - other 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
104 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
105 Axon guidance 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
106 Axon guidance 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
107 Axon guidance 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
108 Axon guidance 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
109 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
110 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
111 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
112 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
113 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
114 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
115 Bile secretion 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
116 Bile secretion 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
117 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
118 Bladder cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
119 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
120 Bladder cancer 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
121 Bladder cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
122 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
123 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
124 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
125 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
126 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
127 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
128 Bladder cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
129 Bladder cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
130 Breast cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
131 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
132 Breast cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
133 Breast cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
134 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
135 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
136 Breast cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
137 Breast cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
138 Breast cancer 💬
 2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
139 Breast cancer 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
140 Breast cancer 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
141 Breast cancer 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
142 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
143 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
144 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
145 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
146 Breast cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
147 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
148 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
149 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
150 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
151 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
152 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
153 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
154 Calcium signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
155 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
156 Calcium signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
157 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
158 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
159 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
160 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
161 Calcium signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
162 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
163 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
164 Calcium signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
165 Calcium signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
166 cAMP signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
167 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
168 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
169 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
170 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
171 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
172 Cell cycle 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
173 Cell cycle 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
174 Cell cycle 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
175 Cellular senescence 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
176 Cellular senescence 💬
 2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
177 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
178 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
179 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
180 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
181 Cellular senescence 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
182 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
183 Cellular senescence 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
184 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
185 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
186 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
187 Central carbon metabolism in cancer 💬
 2件: FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
188 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
189 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
190 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
191 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
192 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
193 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
194 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
195 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
196 Central carbon metabolism in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
197 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
198 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
199 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 14件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
200 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
201 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
202 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
203 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
204 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
205 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
206 Chagas disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
207 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
208 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
209 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
210 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
211 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
212 Chemical carcinogenesis - reactive oxygen species 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
213 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
214 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
215 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
216 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
217 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
218 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
219 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
220 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
221 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
222 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
223 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
224 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
225 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
226 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
227 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
228 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
229 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
230 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
231 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
232 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
233 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
234 Chemical carcinogenesis - receptor activation 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
235 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
236 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
237 Chemokine signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
238 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
239 Chemokine signaling pathway 💬
 1件: CCL2 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
241 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
242 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
243 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
244 Choline metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
245 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
246 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
247 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
248 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
249 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
250 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
251 Choline metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
252 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
253 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
254 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
255 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
256 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
257 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
258 Cholinergic synapse 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
259 Cholinergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
260 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
261 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
262 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
263 Chronic myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
264 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
265 Chronic myeloid leukemia 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
266 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
267 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
268 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
269 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
270 Cocaine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
271 Colorectal cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
272 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
273 Colorectal cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
274 Colorectal cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
275 Colorectal cancer 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
276 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
277 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
278 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
279 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
280 Colorectal cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
281 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
282 Coronavirus disease - COVID-19 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
283 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
284 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
285 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
286 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
287 Coronavirus disease - COVID-19 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
288 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
289 Cushing syndrome 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
290 Cushing syndrome 💬
 1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
291 Cushing syndrome 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
292 Cushing syndrome 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
293 Cushing syndrome 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
294 Cushing syndrome 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
295 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
296 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
297 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
298 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
299 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
300 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
301 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
302 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
303 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
304 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
305 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
306 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
308 Dilated cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
309 Dilated cardiomyopathy 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
310 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
311 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
312 Dopaminergic synapse 💬
 1件: SCN1A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
313 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
314 EGFR tyrosine kinase inhibitor resistance 💬
 3件: AXL, KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
315 EGFR tyrosine kinase inhibitor resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
316 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
317 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
318 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
319 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
320 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
321 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
322 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
323 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
324 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
325 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
326 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
327 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
328 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
329 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
330 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
331 EGFR tyrosine kinase inhibitor resistance 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
332 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
333 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
334 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
335 Endocrine resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
336 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
337 Endocrine resistance 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
338 Endocrine resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
339 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
340 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
341 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
342 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
343 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
344 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
345 Endocrine resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
346 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
347 Endocytosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
348 Endocytosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
349 Endocytosis 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
350 Endocytosis 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
351 Endocytosis 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
352 Endocytosis 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
353 Endometrial cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
354 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
355 Endometrial cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
356 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
357 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
358 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
359 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
360 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
361 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
362 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
363 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
364 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
365 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
366 Epstein-Barr virus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
367 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
368 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
369 Epstein-Barr virus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
370 ErbB signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
371 ErbB signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
372 ErbB signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
373 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
374 ErbB signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
375 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
376 ErbB signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
377 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
378 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
379 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
380 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
381 ErbB signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
382 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
383 Estrogen signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
384 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
385 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
386 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
387 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
388 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
389 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
390 Estrogen signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
391 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
392 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
393 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
394 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
395 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
396 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
397 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
398 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
399 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
400 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
401 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
402 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
403 Fluid shear stress and atherosclerosis 💬
 4件: CCL2, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
404 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
405 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
406 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
407 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
408 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
409 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
410 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
411 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
412 Focal adhesion 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
413 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
414 Focal adhesion 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
415 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
416 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
417 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
418 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
419 Focal adhesion 💬
 5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
420 Focal adhesion 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
421 Focal adhesion 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
422 Focal adhesion 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
423 Focal adhesion 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
424 Focal adhesion 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
425 Focal adhesion 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
426 Focal adhesion 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
427 Focal adhesion 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
428 Focal adhesion 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
429 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
430 FoxO signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
431 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
432 FoxO signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
433 FoxO signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
434 FoxO signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
435 FoxO signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
436 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
437 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
438 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
439 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
440 GABAergic synapse 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
441 Gap junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
442 Gap junction 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
443 Gap junction 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
444 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
445 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
446 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
447 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
448 Gap junction 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
449 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
450 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
451 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
452 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
453 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
454 Gastric cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
455 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
456 Gastric cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
457 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
458 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
459 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
460 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
461 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
462 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
463 Gastric cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
464 Gastric cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
465 Gastric cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
466 Glioma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
467 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
468 Glioma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
469 Glioma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
470 Glioma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
471 Glioma 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
472 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
473 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
474 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
475 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
476 Glioma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
477 Glioma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
478 Glioma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
479 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
480 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
481 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
482 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
483 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
484 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
485 GnRH secretion 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
486 GnRH signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
487 GnRH signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
488 GnRH signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
489 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
490 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
491 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
492 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
493 GnRH signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
494 Graft-versus-host disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
495 Graft-versus-host disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
496 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
497 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
498 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
499 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
500 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
501 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
502 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
503 Hematopoietic cell lineage 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
504 Hematopoietic cell lineage 💬
 3件: CSF1R, FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
505 Hematopoietic cell lineage 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
506 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
507 Hematopoietic cell lineage 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
508 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
509 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
510 Hematopoietic cell lineage 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
511 Hepatitis B 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
512 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
513 Hepatitis B 💬
 1件: IFNAR1 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
514 Hepatitis B 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
515 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
516 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
517 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
518 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
519 Hepatitis B 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
520 Hepatitis C 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
521 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
522 Hepatitis C 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
523 Hepatitis C 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
524 Hepatitis C 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
525 Hepatitis C 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
526 Hepatitis C 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
527 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
528 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
529 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
530 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
531 Hepatitis C 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
532 Hepatitis C 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
533 Hepatocellular carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
534 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
535 Hepatocellular carcinoma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
536 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
537 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
538 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
539 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
540 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
541 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
542 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
543 Hepatocellular carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
544 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
545 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
546 Herpes simplex virus 1 infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
547 Herpes simplex virus 1 infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
548 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
549 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
550 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
551 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
552 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
553 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
554 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
555 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
556 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
557 HIF-1 signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
558 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
559 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
560 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
561 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
562 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
563 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
564 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
565 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
566 Human cytomegalovirus infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
567 Human cytomegalovirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
568 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
569 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
570 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
571 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
572 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
573 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
574 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
575 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
576 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
577 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
578 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
579 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
580 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
581 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
582 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
583 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
584 Human cytomegalovirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
585 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
586 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
587 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
588 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
589 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
590 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
591 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
592 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
593 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
594 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
595 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
596 Human papillomavirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
597 Human papillomavirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
598 Human papillomavirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
599 Human papillomavirus infection 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
600 Human papillomavirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
601 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
602 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
603 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
604 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
605 Human papillomavirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
606 Human papillomavirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
607 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
608 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
609 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
610 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
611 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
612 Human papillomavirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
613 Human papillomavirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
614 Human papillomavirus infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
615 Human papillomavirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
616 Human papillomavirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
617 Human T-cell leukemia virus 1 infection 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
618 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
619 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
620 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
621 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
622 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
623 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
624 Huntington disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
625 Huntington disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
626 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
627 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
628 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
629 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
630 IL-17 signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
631 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
632 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
633 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
634 IL-17 signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
635 Inflammatory bowel disease 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
636 Inflammatory bowel disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
637 Inflammatory mediator regulation of TRP channels 💬
 1件: IL1B 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
638 Influenza A 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
639 Influenza A 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
640 Influenza A 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
641 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
642 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
643 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
644 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
645 Influenza A 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
646 Influenza A 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
647 Influenza A 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
648 Insulin resistance 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
649 Insulin resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
650 Insulin resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
651 Insulin resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
652 Insulin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
653 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
654 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
655 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
656 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
657 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
658 Insulin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
659 Insulin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
660 Intestinal immune network for IgA production 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
661 JAK-STAT signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
662 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
663 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
664 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
665 JAK-STAT signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
666 JAK-STAT signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
667 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
668 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
669 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
670 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
671 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
672 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
673 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
674 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
675 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
676 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
677 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
678 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
679 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
680 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
681 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
682 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
683 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
684 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
685 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
686 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
687 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
688 Legionellosis 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
689 Legionellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
690 Leishmaniasis 💬
 4件: IL10, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
691 Leishmaniasis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
692 Leishmaniasis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
693 Leishmaniasis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
694 Leishmaniasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
695 Lipid and atherosclerosis 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
696 Lipid and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
697 Long-term depression 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
698 Long-term depression 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
699 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
700 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
701 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
702 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
703 Long-term potentiation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
704 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
705 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
706 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
707 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
708 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
709 Longevity regulating pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
710 Longevity regulating pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
711 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
712 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
713 Malaria 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
714 Malaria 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
715 Malaria 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
716 MAPK signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
717 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
718 MAPK signaling pathway 💬
 8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
719 MAPK signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
720 MAPK signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
721 MAPK signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
722 MAPK signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
723 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
724 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
725 MAPK signaling pathway 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
726 MAPK signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
727 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
728 MAPK signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
729 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
730 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
731 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
732 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
733 MAPK signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
734 MAPK signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
735 MAPK signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
736 Measles 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
737 Measles 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
738 Measles 💬
 3件: IL1A, IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
739 Measles 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
740 Melanogenesis 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
741 Melanogenesis 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
742 Melanogenesis 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
743 Melanogenesis 💬
 1件: KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
744 Melanogenesis 💬
 2件: KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
745 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
746 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
747 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
748 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
749 Melanoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
750 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
751 Melanoma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
752 Melanoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
753 Melanoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
754 Melanoma 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
755 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
756 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
757 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
758 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
759 Melanoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
760 Melanoma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
761 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
762 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
763 Metabolic pathways 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
764 Metabolic pathways 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
765 Metabolic pathways 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
766 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
767 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
768 Metabolic pathways 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
769 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
770 MicroRNAs in cancer 💬
 3件: ABL1, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
771 MicroRNAs in cancer 💬
 1件: CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
772 MicroRNAs in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
773 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
774 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
775 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
776 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
777 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
778 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
779 MicroRNAs in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
780 MicroRNAs in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
781 MicroRNAs in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
782 MicroRNAs in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
783 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
784 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
785 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
786 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
787 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
788 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
789 Mineral absorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
790 Morphine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
791 mTOR signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
792 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
793 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
794 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
795 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
796 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
797 mTOR signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
798 mTOR signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
799 mTOR signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
800 mTOR signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
801 Natural killer cell mediated cytotoxicity 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
802 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
803 Natural killer cell mediated cytotoxicity 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
804 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
805 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
806 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
807 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
808 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
809 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
810 Necroptosis 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
811 Necroptosis 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
812 Necroptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
813 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 14件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
814 Neuroactive ligand-receptor interaction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
815 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
816 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
817 Neurotrophin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
818 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
819 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
820 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
821 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
822 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
823 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
824 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
825 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
826 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
827 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
828 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
829 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
830 Neutrophil extracellular trap formation 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
831 NF-kappa B signaling pathway 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
832 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
833 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
834 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
835 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
836 Nicotine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
837 NOD-like receptor signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
838 NOD-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
839 NOD-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
840 Non-alcoholic fatty liver disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
841 Non-alcoholic fatty liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
842 Non-small cell lung cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
843 Non-small cell lung cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
844 Non-small cell lung cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
845 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
846 Non-small cell lung cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
847 Non-small cell lung cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
848 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
849 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
850 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
851 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
852 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
853 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
854 Non-small cell lung cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
855 Non-small cell lung cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
856 One carbon pool by folate 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
857 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
858 Oocyte meiosis 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
859 Oocyte meiosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
860 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
861 Osteoclast differentiation 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
862 Osteoclast differentiation 💬
 1件: CSF1R 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
863 Osteoclast differentiation 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
864 Osteoclast differentiation 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
865 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
866 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
867 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
868 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
869 Osteoclast differentiation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
870 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
871 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
872 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
873 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
874 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
875 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
876 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
877 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
878 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
879 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
880 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
881 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
882 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
883 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
884 p53 signaling pathway 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
885 Pancreatic cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
886 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
887 Pancreatic cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
888 Pancreatic cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
889 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
890 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
891 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
892 Pancreatic cancer 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
893 Pancreatic cancer 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
894 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
895 Pancreatic cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
896 Pancreatic cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
897 Pancreatic cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
898 Pancreatic cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
899 Parathyroid hormone synthesis, secretion and action 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
900 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
901 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
902 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
903 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
904 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
905 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
906 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
907 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
908 Parathyroid hormone synthesis, secretion and action 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
909 Parkinson disease 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
910 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
911 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
912 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
913 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
914 Pathogenic Escherichia coli infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
915 Pathogenic Escherichia coli infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
916 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
917 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
918 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
919 Pathways in cancer 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
920 Pathways in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
921 Pathways in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
922 Pathways in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
923 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
924 Pathways in cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
925 Pathways in cancer 💬
 7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
926 Pathways in cancer 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
927 Pathways in cancer 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
928 Pathways in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
929 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
930 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
931 Pathways in cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
932 Pathways in cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
933 Pathways in cancer 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
934 Pathways in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
935 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
936 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
937 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
938 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
939 Pathways in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
940 Pathways in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
941 Pathways in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
942 Pathways in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
943 Pathways in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
944 Pathways in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
945 Pathways in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
946 Pathways in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
947 Pathways of neurodegeneration - multiple diseases 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
948 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
949 Pathways of neurodegeneration - multiple diseases 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
950 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
951 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
952 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
953 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
954 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
955 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
956 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
957 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
958 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
959 Pathways of neurodegeneration - multiple diseases 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
960 Pathways of neurodegeneration - multiple diseases 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
961 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
962 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
963 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
964 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
965 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
966 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
967 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
968 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
969 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
970 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
971 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
972 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
973 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
974 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
975 Pertussis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
976 Pertussis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
977 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
978 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
979 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
980 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
981 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
982 Phospholipase D signaling pathway 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
983 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
984 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
985 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
986 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
987 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
988 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
989 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
990 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
991 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
992 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
993 PI3K-Akt signaling pathway 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
994 PI3K-Akt signaling pathway 💬
 8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
995 PI3K-Akt signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
996 PI3K-Akt signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
997 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
998 PI3K-Akt signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
999 PI3K-Akt signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
1000 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1001 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1002 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1003 PI3K-Akt signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1004 PI3K-Akt signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1005 PI3K-Akt signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1006 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1007 PI3K-Akt signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1008 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1009 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1010 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1011 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1012 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1013 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1014 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1015 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1016 Platelet activation 💬
 1件: PTGS1 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1017 Platelet activation 💬
 1件: PTGS1 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1018 Platinum drug resistance 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1019 Platinum drug resistance 💬
 1件: ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
1020 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D03899 💬 Doxorubicin 5件: 26, 28, 34, 65, 331 💬
1021 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D00125 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1022 Prion disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1023 Prion disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1024 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1025 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1026 Progesterone-mediated oocyte maturation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1027 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1028 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1029 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
1030 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1031 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1032 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1033 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1034 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1035 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1036 Prolactin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1037 Prostate cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1038 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1039 Prostate cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1040 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1041 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
1042 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1043 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1044 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1045 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1046 Prostate cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1047 Prostate cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1048 Prostate cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1049 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1050 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1051 Proteoglycans in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1052 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1053 Proteoglycans in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1054 Proteoglycans in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1055 Proteoglycans in cancer 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
1056 Proteoglycans in cancer 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1057 Proteoglycans in cancer 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1058 Proteoglycans in cancer 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1059 Proteoglycans in cancer 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1060 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1061 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1062 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1063 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1064 Proteoglycans in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1065 Proteoglycans in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1066 Proteoglycans in cancer 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1067 Proteoglycans in cancer 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1068 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1069 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1070 Rap1 signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1071 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1072 Rap1 signaling pathway 💬
 7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1073 Rap1 signaling pathway 💬
 2件: CSF1R, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1074 Rap1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1075 Rap1 signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1076 Rap1 signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
1077 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1078 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1079 Rap1 signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1080 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1081 Rap1 signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1082 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1083 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1084 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1085 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1086 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1087 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1088 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1089 Ras signaling pathway 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1090 Ras signaling pathway 💬
 8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1091 Ras signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1092 Ras signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1093 Ras signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1094 Ras signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
1095 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1096 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1097 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1098 Ras signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1099 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1100 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1101 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1102 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1103 Ras signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1104 Ras signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1105 Regulation of actin cytoskeleton 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1106 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1107 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1108 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1109 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
1110 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1111 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1112 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1113 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1114 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1115 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1116 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1117 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1118 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1119 Regulation of lipolysis in adipocytes 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1120 Relaxin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1121 Relaxin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1122 Relaxin signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
1123 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1124 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1125 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1126 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1127 Relaxin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1128 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1129 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1130 Renal cell carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1131 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1132 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1133 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1134 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1135 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1136 Renal cell carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1137 Renal cell carcinoma 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1138 Renal cell carcinoma 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1139 Retrograde endocannabinoid signaling 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
1140 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1141 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1142 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1143 Rheumatoid arthritis 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1144 Rheumatoid arthritis 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1145 Rheumatoid arthritis 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1146 Rheumatoid arthritis 💬
 1件: FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1147 Rheumatoid arthritis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1148 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1149 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1150 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1151 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1152 Salmonella infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1153 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1154 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1155 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1156 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1157 Salmonella infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1158 Salmonella infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1159 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1160 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1161 Serotonergic synapse 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1162 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1163 Serotonergic synapse 💬
 3件: GABRB1, GABRB2, GABRB3 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
1164 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1165 Serotonergic synapse 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
1166 Serotonergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1167 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1168 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1169 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1170 Serotonergic synapse 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1171 Shigellosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1172 Shigellosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1173 Shigellosis 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
1174 Shigellosis 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1175 Shigellosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1176 Shigellosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1177 Shigellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1178 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1179 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1180 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1181 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1182 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1183 Small cell lung cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1184 Small cell lung cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1185 Small cell lung cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1186 Small cell lung cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1187 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1188 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1189 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1190 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1191 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1192 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1193 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1194 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1195 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1196 Staphylococcus aureus infection 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1197 Synaptic vesicle cycle 💬
 2件: SLC6A2, SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1198 Systemic lupus erythematosus 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1199 Systemic lupus erythematosus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1200 T cell receptor signaling pathway 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
1201 T cell receptor signaling pathway 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1202 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1203 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1204 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1205 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1206 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1207 T cell receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1208 Taste transduction 💬
 6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 70, 75, 98, 296 💬
1209 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
1210 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
1211 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
1212 Terpenoid backbone biosynthesis 💬
 2件: FNTA, FNTB 💬 D03720 💬 Tipifarnib 1件: 34 💬
1213 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1214 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1215 TGF-beta signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1216 TGF-beta signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1217 Th17 cell differentiation 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1218 Th17 cell differentiation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1219 Th17 cell differentiation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1220 Thermogenesis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1221 Thermogenesis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1222 Thyroid cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1223 Thyroid cancer 💬
 2件: BRAF, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1224 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1225 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1226 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1227 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1228 Thyroid cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1229 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1230 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1231 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1232 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1233 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1234 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1235 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1236 Tight junction 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
1237 Tight junction 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1238 Tight junction 💬
 1件: ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
1239 TNF signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1240 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1241 TNF signaling pathway 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
1242 TNF signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1243 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1244 TNF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1245 TNF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1246 TNF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1247 TNF signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1248 Toll-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1249 Toll-like receptor signaling pathway 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1250 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1251 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1252 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1253 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1254 Toll-like receptor signaling pathway 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
1255 Toll-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1256 Toxoplasmosis 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1257 Toxoplasmosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1258 Transcriptional misregulation in cancer 💬
 3件: CSF1R, FLT1, FLT3 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1259 Transcriptional misregulation in cancer 💬
 2件: CSF1R, FLT3 💬 D11270 💬 Pexidartinib 1件: 34 💬
1260 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1261 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1262 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1263 Transcriptional misregulation in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1264 Transcriptional misregulation in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1265 Tuberculosis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1266 Tuberculosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1267 Tuberculosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1268 Tuberculosis 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
1269 Type I diabetes mellitus 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1270 Type I diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1271 Type II diabetes mellitus 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1272 Type II diabetes mellitus 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
1273 Type II diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1274 Type II diabetes mellitus 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1275 Vascular smooth muscle contraction 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1276 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1277 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1278 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1279 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1280 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1281 VEGF signaling pathway 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1282 VEGF signaling pathway 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
1283 VEGF signaling pathway 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1284 VEGF signaling pathway 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1285 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1286 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1287 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1288 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1289 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1290 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
1291 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1292 VEGF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1293 VEGF signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
1294 VEGF signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1295 Viral carcinogenesis 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1296 Viral myocarditis 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1297 Viral myocarditis 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1298 Viral protein interaction with cytokine and cytokine receptor 💬
 4件: CCL2, IL10, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1299 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
1300 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1R 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1301 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1302 Yersinia infection 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1303 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1304 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
1305 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1306 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1307 Yersinia infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬

先頭へ